Obesity management is entering a digital-first era. For decades, weight management has largely depended on periodic consultations, standardized diet plans, and patient self-reporting. ... Aug 12
Supported by the Office of the Principal Scientific Advisor to the Government of India, the Department of Pharmaceuticals, Biotechnology Industry Research Assistance Council, and Invest ... Jun 03
Prescription only, limited duration dosing regimen guided by amyloid plaque removal.... May 14
Campaign blends lived experiences with science led perspectives to challenge obesity stigma and emphasise the importance of guidance from doctors.... Feb 28
In a key secondary endpoint, participants on orforglipron 36 mg lost 19.7 lbs (8.9 kg ;9.2%) compared to 11.0 lbs (5 ... Feb 28
Very recently, two global giants, NVIDIA and Eli Lilly and Company had announced a first-of-its-kind AI co-innovation lab focused on applying ... Feb 20
Global innovators shaping AI-native biology, next-generation medicines and digital-first healthcare to chart the future of global health.... Feb 05
The obesity epidemic is vast. The solutions are emerging. Science is evolving. And the market is expanding. The launch of Yurpeak is another step in ... Dec 12
Eli Lilly and Company (India) Pvt. Ltd. today announced that the Central Drugs Standard Control Organization (CDSCO) has granted marketing authorization for donanemab for the ... Nov 19
As the patent clock ticks towards 2026, both Novo and Lilly are likely to intensify their efforts in expanding supply chains, boosting physician engagement, and ... Nov 14
In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint. In ACHIEVE-5, orforglipron ... Oct 16
In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint. In ACHIEVE-5, orforglipron ... Oct 15
Investment to expand manufacturing and global medicine supply capacity — resonating with the Make in India agenda.... Oct 06
Participants with obesity or overweight and type 2 diabetes, a population with increased difficulties losing weight, lost an average of 10.4 kg (10.5%) ... Aug 28
Long-term effects of GLP-1 medications remain under investigation, and shifting to easy-to-use pens removes barriers but not risks.... Aug 16
Hyderabad site will support innovation and strengthen digital capabilities across Lilly’s global operations.... Aug 04
Mounjaro met the primary objective of non-inferiority vs. Trulicity with an 8% lower rate of MACE-3 events, while delivering greater reductions in A1C ... Aug 01
As India confronts an alarming rise in obesity and related conditions like type 2 diabetes, cardiovascular disease, and polycystic ovarian syndrome, the spotlight on medical ... Jun 25
Lilly plans to submit efsitora for the treatment of adults with type 2 diabetes to global regulatory agencies by the end of this year.... Jun 23
Eli Lilly and Company (India) has entered into a partnership with Apollo Clinic, a prominent clinic network under Apollo Health and Lifestyle, and Apollo HealthCo. ... May 29
... May 12
... Mar 20
Winselow holds a bachelors degree in business administration from Howard University and a Master of Business Administration from Indiana University.... Feb 04
With a focus on affordability, accessibility, and innovation, Lupin is leading the way for better diabetes management and improved quality of life for patients.... Jan 03
While the quest for a cure for dementia continues, the potential for prevention through addressing risk factors offers hope.... Aug 03
-Advertisements-
.jpeg)
Thursday, October 08, 2026
.jpg)
.jpg)
.jpg)
_11zon.jpeg)
.jpeg)
.png)
.jpeg)
.jpg)
.jpeg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)